2022 | Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas
| TRANSLATIONAL ONCOLOGY |
2022 | Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers
| FRONTIERS IN ONCOLOGY |
2022 | First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea | ANTICANCER RESEARCH |
2022 | Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis
| TRANSLATIONAL ONCOLOGY |
2022 | Malignant thoracic lymph node classification with deep convolutional neural networks on real-time endobronchial ultrasound (EBUS) images
| TRANSLATIONAL LUNG CANCER RESEARCH |
2022 | ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model
| YONSEI MEDICAL JOURNAL |
2021 | Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
| TRANSLATIONAL LUNG CANCER RESEARCH |
2021 | Is Methionyl-tRNA Synthetase Applicable as a Diagnostic Marker for Lung Cancer in Bronchial Ultrasound-Guided Brushing Cells? | DIAGNOSTICS |
2021 | Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea | CANCER MEDICINE |
2021 | Methionyl-tRNA synthetase and aminoacyl-tRNA synthetases interacting multi-functional protein-lacking exon 2 as potential diagnostic biomarkers for lung cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
2021 | Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting | THORACIC CANCER |
2021 | 폐암의 바이오마커와 진단도구
| JOURNAL OF THE KOREAN MEDICAL ASSOCIATION |
2020 | Prediction model for hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitors | THORACIC CANCER |
2020 | Brain Metastases From Lung Adenocarcinoma May Preferentially Involve the Distal Middle Cerebral Artery Territory and Cerebellum
| FRONTIERS IN ONCOLOGY |
2020 | Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation | CANCER BIOLOGY & THERAPY |
2020 | Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes
| TRANSLATIONAL LUNG CANCER RESEARCH |
2020 | Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer
| RESPIRATORY RESEARCH |
2020 | An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody | BIOMOLECULES |
2020 | Recent advances in diagnostic technologies in lung cancer
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2020 | Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation-Positive Lung Adenocarcinoma
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2019 | Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
| THORACIC CANCER |
2019 | Methionyl-tRNA Synthetase is a Useful Diagnostic Marker for Lymph Node Metastasis in Non-Small Cell Lung Cancer
| YONSEI MEDICAL JOURNAL |
2019 | Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation | Journal of Cancer |
2019 | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2018 | Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
| BMC CANCER |
2018 | Safety of endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer within a year after percutaneous coronary intervention. | THORACIC CANCER |
2018 | High versus low attenuation thresholds to determine the solid component of ground-glass opacity nodules.
| PLOS ONE |
2018 | Usefulness of Bronchoscopic Rebiopsy of Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
| JOURNAL OF CANCER |
2018 | Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2017 | Lessons learned from continued TB outbreaks in a high school
| PLOS ONE |
2017 | Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome.
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2017 | The repeatability of computed tomography lung volume measurements: Comparisons in healthy subjects, patients with obstructive lung disease, and patients with restrictive lung disease. | PLOS ONE |
2017 | MYC expression correlates with PD-L1 expression in non-small cell lung cancer | LUNG CANCER |
2017 | Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer
| BMC CANCER |
2017 | ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
| NEOPLASIA |
2017 | Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer
| JOURNAL OF CANCER |
2017 | Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2016 | Association of Specific Immunoglobulin E to Staphylococcal Enterotoxin with Airway Hyperresponsiveness in Asthma Patients
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2016 | Mechanisms of epidermal growth factor receptor tyrosine kinase inhibitor resistance and strategies to overcome resistance in lung adenocarcinoma
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2016 | The feasibility of CT lung volume as a surrogate marker of donor-recipient size matching in lung transplantation | MEDICINE |
2016 | Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
| CANCER BIOLOGY & THERAPY |
2016 | Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
| BMC CANCER |
2015 | BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis | LUNG CANCER |
2015 | Anastomotic Airway Complications after Lung Transplantation
| YONSEI MEDICAL JOURNAL |
2015 | A rare case of primary thymic adenocarcinoma mimicking small cell lung cancer
| TUBERCULOSIS AND RESPIRATORY DISEASES |
2015 | Diagnostic utility of interferon-gamma release assay in extrapulmonary tuberculosis | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE |
2015 | AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical models | CANCER LETTERS |
2015 | Effects of blood lead levels on airflow limitations in Korean adults: findings from the 5th KNHNES 2011 | ENVIRONMENTAL RESEARCH |
2015 | Efficacy of surgical treatment for brain metastasis in patients with non-small cell lung cancer
| YONSEI MEDICAL JOURNAL |
2014 | KRAS oncogene substitutions in Korean NSCLC patients: Clinical implication and relationship with pAKT and RalGTPases expression | LUNG CANCER |